Orthofix Medical Inc. Payments for Merger Related Costs
Orthofix Medical Inc. (OFIX) reported Payments for Merger Related Costs of $572.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForMergerRelatedCosts · last filed 2026-08-05
- Orthofix Medical Inc. payments for merger related costs for the quarter ending 2026-06-30 was $572.00K, a 88.29% decline year-over-year.
- Orthofix Medical Inc. payments for merger related costs for the quarter ending 2026-03-31 was $69.00K, a 93.89% decline year-over-year.
- Orthofix Medical Inc. payments for merger related costs for the quarter ending 2025-12-31 was -$49.00K, a 103.28% decline year-over-year.
- Orthofix Medical Inc. payments for merger related costs for the quarter ending 2025-09-30 was $126.00K, a 95.18% decline year-over-year.
- Orthofix Medical Inc. payments for merger related costs for fiscal 2025 was $6.09M, a 57.94% decline from fiscal 2024.
- Orthofix Medical Inc. payments for merger related costs for fiscal 2024 was $14.48M, a 60.40% decline from fiscal 2023.
- Orthofix Medical Inc. payments for merger related costs for fiscal 2023 was $36.58M, a 207.32% increase from fiscal 2022.
- Orthofix Medical Inc. payments for merger related costs for fiscal 2022 was $11.90M.
| Period end | Payments for Merger Related Costs 3 month | Payments for Merger Related Costs 3 month as first filed | Payments for Merger Related Costs 6 month | Payments for Merger Related Costs 9 month | Payments for Merger Related Costs 12 month | Payments for Merger Related Costs 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $572.00K 10-Q · filed 2026-08-05 | $503.00K 10-Q · filed 2026-08-05 | $592.00K derived: sum of 3 quarters · filed 2026-08-05 | $718.00K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $69.00K 10-Q · filed 2026-05-05 | $20.00K derived: sum of 2 quarters · filed 2026-05-05 | $146.00K derived: sum of 3 quarters · filed 2026-05-05 | $5.03M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $77.00K derived: sum of 2 quarters · filed 2026-02-24 | $4.96M derived: sum of 3 quarters · filed 2026-08-05 | $6.09M 10-K · filed 2026-02-24 | ||
| 2025-09-30 | $126.00K 10-Q · filed 2025-11-04 | $5.01M derived: sum of 2 quarters · filed 2026-08-05 | $6.14M 10-Q · filed 2025-11-04 | $7.63M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $4.89M 10-Q · filed 2026-08-05 | $6.02M 10-Q · filed 2026-08-05 | $7.51M derived: sum of 3 quarters · filed 2026-08-05 | $10.13M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $1.13M 10-Q · filed 2026-05-05 | $2.62M derived: sum of 2 quarters · filed 2026-05-05 | $5.24M derived: sum of 3 quarters · filed 2026-05-05 | $11.14M derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $4.11M derived: sum of 2 quarters · filed 2026-02-24 | $10.01M derived: sum of 3 quarters · filed 2026-02-24 | $14.48M 10-K · filed 2026-02-24 | ||
| 2024-09-30 | $2.62M 10-Q · filed 2025-11-04 | $8.51M derived: sum of 2 quarters · filed 2025-11-04 | $12.99M 10-Q · filed 2025-11-04 | $15.21M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-06-30 | $5.90M 10-Q · filed 2025-08-05 | $10.38M 10-Q · filed 2025-08-05 | $12.59M derived: sum of 3 quarters · filed 2026-02-24 | $18.01M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | $4.48M 10-Q · filed 2025-05-06 | $4.52M 10-Q · filed 2024-05-07 | $6.69M derived: sum of 2 quarters · filed 2026-02-24 | $12.11M derived: sum of 3 quarters · filed 2026-02-24 | $20.32M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $7.63M derived: sum of 2 quarters · filed 2026-02-24 | $15.84M derived: sum of 3 quarters · filed 2026-02-24 | $36.58M 10-K · filed 2026-02-24 | $36.62M 10-K · filed 2024-03-05 | |
| 2023-09-30 | $5.42M 10-Q · filed 2024-11-07 | $13.62M derived: sum of 2 quarters · filed 2024-11-07 | $34.36M 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | $8.21M 10-Q · filed 2024-08-06 | $28.95M 10-Q · filed 2024-08-06 | ||||
| 2023-03-31 | $20.74M 10-Q · filed 2024-05-07 | |||||
| 2022-12-31 | $11.90M 10-K · filed 2025-02-25 | $12.01M 10-K · filed 2024-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |